Delivery Order SPE2DR25D2206-SPE2DR26F9GN9
- Not listed
- The Defense Logistics Agency (DLA) awarded a $13,715.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, with an ultimate completion date of November 18, 2025. This non-competitive delivery order was issued on November 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for Vivitrol 380 mg vial-diluents with a ceiling value of $1,055.07. This is a firm fixed price delivery order with an ultimate completion date of December 10, 2025, and represents a non-competitive award under an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,715.91 on November 26, 2025, for the supply of Vivitrol 380 mg vials with diluents. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 28, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Vivitrol 380 mg vial-diluents with a ceiling value of $5,005.80. This firm fixed price delivery order, with an ultimate completion date of November 7, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents under a firm fixed-price contract with a ceiling value of $5,167.16. The award was made on December 15, 2025, with an ultimate completion date of December 16, 2025. This non-set-aside delivery order represents a single procurement from AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents, valued at $1,269.91. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 28, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Vivitrol 380 mg vials and diluents, with a ceiling value of $7,385.49. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The contract calls for delivery to the company's headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Vivitrol 380 mg vial-diluents, with a contract ceiling value of $9,379.02 and an ultimate completion date of October 24, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning the award was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Vivitrol 380 mg vial-diluents with a ceiling value of $13,236.00 under a firm fixed-price contract structure. This competitively awarded, non-set-aside delivery order is scheduled for completion by June 17, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency (DLA) awarded a $6,007.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vivitrol 380 mg vials and diluents. This is a non-set-aside contract with an ultimate completion date of August 13, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9GN9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents with a ceiling value of $14,756.89. The contract, issued on December 18, 2025, utilizes a firm fixed price structure with an ultimate completion date of December 19, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The award was made through open competition with no set-aside designation, and performance will take place at AmerisourceBergen's Conshohocken, Pennsylvania location. Vivitrol (naltrexone) is an FDA-approved medication used for opioid dependence treatment and alcohol use disorder, making this pharmaceutical supply critical for military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a primary vendor for federal medical procurement through its comprehensive SPE2DX vehicle, which supports the Defense Health Agency and other military healthcare programs globally. This delivery order reflects the company's continued role as a key supplier of specialized pharmaceuticals and medical supplies to support the Department of Defense's medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.8k | 12/17/25 |